Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Pulmonary hypertension in end-stage renal disease and post renal transplantation patients Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013
Autonomic dysfunction, cardio-pulmonary parameters and masked heart failure in non-severe chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function Year: 2020
Tuberculosis in patients with chronic renal failure Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006
Pulmonary hypertension in patients with chronic myeloproliferative disorders Source: Eur Respir Rev 2015; 24: 400-410 Year: 2015
Bronchiectasis-related amyloidosis as a cause of chronic renal failure Source: Eur Respir J 2002; 20: Suppl. 38, 445s Year: 2002
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010
Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency Source: Eur Respir J 2014; 44: 821-822 Year: 2014
Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency Source: Eur Respir J 2014; 44: 819-821 Year: 2014
Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2011; 39: 51-58 Year: 2012
Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2012; 39: 51-58 Year: 2012
Pulmonary endothelial dysfunction in chronic obstructive pulmonary disease Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy Year: 2016
Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010
Endothelial dysfunction in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011
Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006
Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019
Managing deteriorations in chronic obstructive pulmonary disease: which organ is failing? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018
Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002
Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
Renal function reserve in patients with mild and moderate chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 56s Year: 2005